The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy.
about
Pneumococcal infection of respiratory cells exposed to welding fumes; Role of oxidative stress and HIF-1 alphaPossible Risk Factors of Pulmonary Metastases in Patients With International Federation of Gynecology and Obstetrics Stage I Endometrioid-Type Endometrial Cancer.Liquid-based three-dimensional tumor models for cancer research and drug discovery.PAFR selectively mediates radioresistance and irradiation-induced autophagy suppression in prostate cancer cells.Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.Hypoxia metabolism in ageing
P2860
The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The expression of platelet-act ...... arget for combination therapy.
@ast
The expression of platelet-act ...... arget for combination therapy.
@en
type
label
The expression of platelet-act ...... arget for combination therapy.
@ast
The expression of platelet-act ...... arget for combination therapy.
@en
prefLabel
The expression of platelet-act ...... arget for combination therapy.
@ast
The expression of platelet-act ...... arget for combination therapy.
@en
P2093
P2860
P356
P1476
The expression of platelet-act ...... arget for combination therapy.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2014.323
P407
P50
P577
2014-06-12T00:00:00Z
P5875
P6179
1041437998